Secondary cytoreduction for relapsed ovarian cancer

Volume: 22, Issue: 6, Pages: e231 - e231
Published: Jun 1, 2021
Abstract
Tingyan Shi and colleagues 1 Shi T Zhu J Feng Y et al. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2021; 22: 439-449 Summary Full Text Full Text PDF PubMed Scopus (9) Google Scholar report, in The Lancet Oncology, their findings from the SOC-1 trial, on which Debra Richardson wrote a Comment....
Paper Details
Title
Secondary cytoreduction for relapsed ovarian cancer
Published Date
Jun 1, 2021
Journal
Volume
22
Issue
6
Pages
e231 - e231
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.